Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

205.47 -1.85 (-0.89%)

Streaming Delayed Price Updated: 3:47 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

99 100 Next >

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? ↗

May 04, 2025

Via The Motley Fool

Johnson & Johnson - Elliott Wave Technical Analysis ↗

May 02, 2025

We are tracking a potential major bottom forming in Primary wave 2. A clear five-wave move into wave {i} suggests the early stages of an upside trend resumption.

Via Talk Markets

40-Year-Old Making $4K a Month in Dividends Reveals His Top 8 Stocks — 'We Don't Wear Fancy Clothes or Spend Money on Impressing Others' ↗

May 01, 2025

Via Benzinga

8 Health Care Stocks Whale Activity In Today's Session ↗

May 01, 2025

Via Benzinga

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗

May 01, 2025

Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?

Via Investor's Business Daily

Topics Animal Testing Economy Government

Nvidia, Johnson & Johnson, Hyundai, Toyota, SoftBank CEOs To Join Trump At White House As He Touts Investment Surge In First 100 Days: Report ↗

April 29, 2025

Trump to highlight investments from top companies, including Nvidia, J&J, and Toyota, in 'Investing in America' event to mark first 100 days in office.

Via Benzinga

Topics Government

Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference

April 28, 2025

From Johnson & Johnson

Via Business Wire

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications ↗

April 28, 2025

A lawsuit claims Eli Lilly, Johnson & Johnson, and Kaiser Permanente failed to warn consumers about breast cancer risks linked to their antipsychotic drugs Risperdal and Zyprexa.

Via Benzinga

Topics Lawsuit

AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst ↗

April 28, 2025

Analysts raise AbbVie price targets after strong Q1 results, driven by Skyrizi, Rinvoq growth and strategic moves in Parkinson's disease treatments.

Via Benzinga

CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug ↗

April 28, 2025

The companies are working on treatments for a form of bladder cancer.

Via Investor's Business Daily

3 Industry Behemoths Are Rewarding Investors With Dividend Bumps

April 28, 2025

See these three stocks that are among the most important in their industries, which have announced sizable increases in their dividends.

Via MarketBeat

Topics World Trade

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

April 28, 2025

See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.

Via MarketBeat

Topics Artificial Intelligence Economy Government

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys? ↗

April 26, 2025

Via The Motley Fool

Topics Economy Government Lawsuit

3 Dividend Kings That Have Raised Their Payouts in 2025 ↗

April 24, 2025

Via The Motley Fool

Topics Economy

In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now ↗

April 24, 2025

Short-term tariff uncertainty marks the perfect opportunity for long-term investors to snag some amazing deals.

Via The Motley Fool

Topics Economy Government Stocks

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 23, 2025

Global pharmaceutical company Merck (NYSE:MRK) will be reporting results tomorrow before market hours. Here’s what to expect.

Via StockStory

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

April 23, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗

April 23, 2025

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.

Via Benzinga

Topics Government

JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations

April 22, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion. The company’s full-year revenue...

Via StockStory

Topics Earnings World Trade

Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income ↗

April 22, 2025

Via Benzinga

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs ↗

April 22, 2025

Roche to invest $50 billion in U.S. over five years, adding 12,000+ jobs and expanding manufacturing, R&D, and export capacity across eight states.

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

April 22, 2025

Via Benzinga

Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?

April 22, 2025

Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $157.30. However, the stock is beating the S&P 500’s 11% decline during that...

Via StockStory

Topics Stocks

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government ↗

April 20, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline ↗

April 19, 2025

Via Benzinga

Stocks That Weathered Past Recessions: Expert Shares Picks That Withstood Every Downturn ↗

April 19, 2025

Stock market expert Jon Erlichman recently shared a review of stock returns during the last six U.S. recessions, highlighting those that have performed well in difficult times.

Via Benzinga

The SWAN (Sleep Well At Night) Blueprint Revealed ↗

April 19, 2025

I’ve adopted “SWAN,” which stands for

Via Talk Markets

Topics Stocks / Equities

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now ↗

April 19, 2025

Via The Motley Fool

Topics Bonds

ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot ↗

April 18, 2025

Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.

Via Benzinga

Topics ETFs

Where Will Eli Lilly Be in 5 Years? ↗

April 18, 2025

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

All News about Johnson & Johnson

Starting at $3.75/week.

Subscribe Today